Adam Crystal, Chief Medical Officer at C4 Therapeutics, Inc. (CCCC), sold 28,946 shares at $31.59 ($916K) on 2022-01-04, disclosed to the SEC on 2022-01-05.
Open-market sale of $916k CCCC by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.59 | 13,946 | $441K | 48.1% |
| 2 | $31.59 | 13,946 | $441K | 48.1% |
| 3 | $32.66 | 1,054 | $34K | 3.8% |
| Total | $31.63 avg | 28,946 | $916K | 100% |
| Filing → |
| TNGX | SELL | 2026-08-05 | $736K | — | Filing → |
| TNGX | SELL | 2026-07-02 | $799K | — | Filing → |
| TNGX | SELL | 2026-06-03 | $618K | — | Filing → |